Search Results - "Painter, Meghan M."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) by Atagi, Yuka, Liu, Chia-Chen, Painter, Meghan M., Chen, Xiao-Fen, Verbeeck, Christophe, Zheng, Honghua, Li, Xia, Rademakers, Rosa, Kang, Silvia S., Xu, Huaxi, Younkin, Steven, Das, Pritam, Fryer, John D., Bu, Guojun

    Published in The Journal of biological chemistry (23-10-2015)
    “…Several heterozygous missense mutations in the triggering receptor expressed on myeloid cells 2 (TREM2) have recently been linked to risk for a number of…”
    Get full text
    Journal Article
  2. 2

    Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes by Zhao, Na, Liu, Chia-Chen, Van Ingelgom, Alexandra J., Martens, Yuka A., Linares, Cynthia, Knight, Joshua A., Painter, Meghan M., Sullivan, Patrick M., Bu, Guojun

    Published in Neuron (Cambridge, Mass.) (27-09-2017)
    “…Diabetes and impaired brain insulin signaling are linked to the pathogenesis of Alzheimer’s disease (AD). The association between diabetes and AD-associated…”
    Get full text
    Journal Article
  3. 3

    Apolipoprotein E as a Therapeutic Target in Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence by Yamazaki, Yu, Painter, Meghan M., Bu, Guojun, Kanekiyo, Takahisa

    Published in CNS drugs (01-09-2016)
    “…Alzheimer’s disease (AD) is a devastating neurodegenerative disorder that causes progressive cognitive decline. The majority of AD cases are sporadic and…”
    Get full text
    Journal Article
  4. 4

    TREM2 in CNS homeostasis and neurodegenerative disease by Painter, Meghan M, Atagi, Yuka, Liu, Chia-Chen, Rademakers, Rosa, Xu, Huaxi, Fryer, John D, Bu, Guojun

    Published in Molecular neurodegeneration (04-09-2015)
    “…Myeloid-lineage cells accomplish a myriad of homeostatic tasks including the recognition of pathogens, regulation of the inflammatory milieu, and mediation of…”
    Get full text
    Journal Article
  5. 5

    Antidepressants at environmentally relevant concentrations affect predator avoidance behavior of larval fathead minnows (Pimephales promelas) by Painter, Meghan M, Buerkley, Megan A, Julius, Matthew L, Vajda, Alan M, Norris, David O, Barber, Larry B, Furlong, Edward T, Schultz, Melissa M, Schoenfuss, Heiko L

    Published in Environmental toxicology and chemistry (01-12-2009)
    “…The effects of embryonic and larval exposure to environmentally relevant (ng/L) concentrations of common antidepressants, fluoxetine, sertraline, venlafaxine,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Antiviral Protection via RdRP-Mediated Stable Activation of Innate Immunity by Painter, Meghan M, Morrison, James H, Zoecklein, Laurie J, Rinkoski, Tommy A, Watzlawik, Jens O, Papke, Louisa M, Warrington, Arthur E, Bieber, Allan J, Matchett, William E, Turkowski, Kari L, Poeschla, Eric M, Rodriguez, Moses

    Published in PLoS pathogens (01-12-2015)
    “…For many emerging and re-emerging infectious diseases, definitive solutions via sterilizing adaptive immunity may require years or decades to develop, if they…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows by Schultz, Melissa M., Painter, Meghan M., Bartell, Stephen E., Logue, Amanda, Furlong, Edward T., Werner, Stephen L., Schoenfuss, Heiko L.

    Published in Aquatic toxicology (01-07-2011)
    “…Antidepressant pharmaceuticals have been reported in wastewater effluent at the nanogram to low microgram-per-liter range, and include bupropion (BUP),…”
    Get full text
    Journal Article
  10. 10

    Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders by Watzlawik, Jens O., Kahoud, Robert J., Ng, Shermayne, Painter, Meghan M., Papke, Louisa M., Zoecklein, Laurie, Wootla, Bharath, Warrington, Arthur E., Carey, William A., Rodriguez, Moses

    Published in Journal of neurochemistry (01-09-2015)
    “…CNS regeneration is a desirable goal for diseases of brain and spinal cord. Current therapeutic strategies for the treatment of multiple sclerosis (MS) aim to…”
    Get full text
    Journal Article
  11. 11

    Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire by Watzlawik, Jens O, Wootla, Bharath, Painter, Meghan M, Warrington, Arthur E, Rodriguez, Moses

    Published in Expert review of neurotherapeutics (01-09-2013)
    “…Immunoglobulins with germline sequences occur in invertebrates and vertebrates and are named naturally occurring autoantibodies (NAbs). NAbs may target foreign…”
    Get more information
    Journal Article
  12. 12

    Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study by Watzlawik, Jens O, Kahoud, Robert J, Wootla, Bharath, Painter, Meghan M, Warrington, Arthur E, Carey, William A, Rodriguez, Moses

    Published in Journal of visualized experiments (29-06-2016)
    “…Antibodies of the IgM isotype are often neglected as potential therapeutics in human trials, animal models of human diseases as well as detecting agents in…”
    Get full text
    Journal Article
  13. 13

    Polysialic acid as an antigen for monoclonal antibody HI gM12 to treat multiple sclerosis and other neurodegenerative disorders by Watzlawik, Jens O., Kahoud, Robert J., Ng, Shermayne, Painter, Meghan M., Papke, Louisa M., Zoecklein, Laurie, Wootla, Bharath, Warrington, Arthur E., Carey, William A., Rodriguez, Moses

    Published in Journal of neurochemistry (01-09-2015)
    “…Abstract CNS regeneration is a desirable goal for diseases of brain and spinal cord. Current therapeutic strategies for the treatment of multiple sclerosis (…”
    Get full text
    Journal Article
  14. 14

    Antiviral Protection via RdRP-Mediated Stable Activation of Innate Immunity: e1005311 by Painter, Meghan M, Morrison, James H, Zoecklein, Laurie J, Rinkoski, Tommy A, Watzlawik, Jens O, Papke, Louisa M, Warrington, Arthur E, Bieber, Allan J, Matchett, William E, Turkowski, Kari L, Poeschla, Eric M, Rodriguez, Moses

    Published in PLoS pathogens (01-12-2015)
    “…For many emerging and re-emerging infectious diseases, definitive solutions via sterilizing adaptive immunity may require years or decades to develop, if they…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Antiviral Protection via RdRP-Mediatedy Stable Activation of Innate Immunit by Painter, Meghan M

    Published 01-01-2015
    “…All RNA viruses encode RNA-dependent RNA polymerases (RdRPs) which produce viral replication intermediates that trigger acute innate immune activation through…”
    Get full text
    Dissertation
  17. 17